Summary
IBD Chart
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Launched on 07/10/2017, the Inspire Corporate Bond ETF (IBD) is a smart beta exchange traded fund offering broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
Spyre: Maintain 'Strong Buy' On Additional SPY072 Shots On Goal Q4 2026 And IBD Combination Potential
Spyre Therapeutics maintains a 'Strong Buy' rating, driven by promising IBD pipeline progress and robust cash reserves. SYRE's three monotherapy candidates—SPY001, SPY002, SPY003—show potential best-in-class efficacy for IBD, with combination data expected in 2027. Despite discontinuing SPY072 monotherapy for RA, SYRE retains upside via upcoming PsA, axSpA, and combination readouts in late 2026–2028.
Can Spyre's SPY772 HS Study Broaden Its Growth Story Beyond Core IBD?
SYRE expands into HS with SPY772, testing whether dual-pathway inhibition can strengthen outcomes in SKYLIGHT.
Inspire Corporate Bond ETF Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 29,217 | $694,480 | $676,373.55 | -$18,106.45 | -2.61% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 29,051 | $693,679.91 | $672,530.65 | -$21,149.26 | -3.05% |
| MA mason adams PVG ASSET MANAGEMENT Corp. | 10,488 | $250,121.1 | $243,635.19 | -$6,485.91 | -2.59% |
| BR Bill Reuther SILVER OAK SECURITIES Inc.ORPORATED | 41,930 | $1.01M | $972,469.91 | -$33,779.12 | -3.36% |
| LW Landry Watson AVANTAX ADVISORY SERVICES Inc. | 28,693 | $708,377.09 | $665,390.67 | -$42,986.42 | -6.07% |
Inspire Corporate Bond ETF (IBD) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Inspire Corporate Bond ETF ever had a stock split?
Inspire Corporate Bond ETF Profile
| ARCA Exchange | US Country |
Overview
The company operates within the financial sector, focusing on investment services that prioritize not only financial returns but also positive social impact. It practices a selective investment strategy, dedicating a significant portion of its portfolio to domestic corporate bonds. These bonds are issued by financially robust companies, specifically those with a market capitalization of $5 billion or more. Additionally, the firm places a strong emphasis on the creditworthiness of these entities, requiring a minimum credit rating of BBB- from Standard and Poor's or Baa3 from Moody's. An innovative aspect of its investment approach is the incorporation of the Inspire Impact Score®, ensuring that the assets they invest in contribute positively to society on top of generating financial returns. This approach indicates a commitment not only to the financial health of their investments but also to broader social and ethical considerations.
Products and Services
- Domestic Corporate Bonds Investment
- Inspire Impact Score® Evaluation
This service focuses on investing in high-quality corporate bonds, specifically those issued by companies with substantial market capitalizations of $5 billion or more. The selection process is stringent, with an emphasis on financial stability and creditworthiness, requiring a minimum credit rating of BBB- or Baa3 from recognized credit rating agencies. This ensures that the investments are not only sound financially but also resilient in various market conditions.
As part of its distinctive investment approach, the company assesses potential investments using the Inspire Impact Score®, a proprietary tool that measures the social and environmental impact of companies. This evaluation ensures that investments align with broader societal values, contributing to positive social and environmental outcomes alongside financial returns. It reflects the company's commitment to responsible investing, prioritizing assets that fulfill both ethical standards and financial criteria.
Contact Information
